Introduction
============

Chronic renal failure is an independent risk factor for coronary diseases and their complications. The severity of injuries is inversely proportional to glomerular filtration rate and, for this reason, ischemic cardiovascular diseases are the main cause of mortality in these patients.^[@r1],[@r2]^ In addition to uremia, other factors including poor quality of distal coronary bed, hyperhomocysteinemia, increased calcium-phosphorus product, oxidative stress and exacerbated inflammatory and atherosclerotic status are associated with coronary disease severity.^[@r3]-[@r6]^ Myocardial revascularization surgery has demonstrated higher long-term survival and lower risk for myocardial infarction and cardiovascular death as compared with coronary angioplasty in chronic renal failure patients on hemodialysis. However, surgical intervention still results in high morbidity and mortality in these patients.^[@r7]-[@r11]^

Myocardial revascularization surgery without extracorporeal circulation (ECC) has benefits when compared with its use, including lower inflammatory response, less embolization of atherosclerotic material, lower requirement for blood transfusion and vasoactive drugs, shorter time of mechanical ventilation and shorter stay in the intensive care unit (ICU).^[@r12]-[@r14]^ National and international articles have suggested an association between the use of ECC and postoperative morbidity and mortality.^[@r15],[@r16]^

Objectives
==========

To evaluate the effect of the use of ECC on the in-hospital outcomes of patients with chronic renal failure on hemodialysis following myocardial revascularization surgery, trying to identify the best surgical strategy for this group of patients.

Medical records of 102 consecutive, unselected patients with chronic renal failure on dialytic therapy, who underwent myocardial revascularization surgery in a public tertiary university hospital in the period from 2007 to 2014 were assessed. Patients undergoing other concomitant procedures (e.g. heart valve, carotid, aortic surgeries) and patients with previous cardiac surgery were excluded. We assessed demographic, clinical and intraoperative data, and postoperative complications during patients\' hospital stay. Preoperative risk was calculated by the *European System for Cardiac Operative Risk Evaluation II* (EuroSCORE II).^[@r17]^ The study group was divided into two subgroups (\"with ECC\" and \"without ECC\"). The study was approved by the local ethics committee.

Surgical technique
------------------

Indication for myocardial revascularization surgery was based on national and international guidelines.^[@r18]-[@r20]^ Surgical planning was based on injuries detected by cineangiography, feasibility of surgical revascularization of distal coronary bed, and choice of the best vascular graft for each coronary artery. The choice of using or not using ECC was at the surgeon\'s discretion. In the operating room, central venous access was obtained, and invasive medication for blood pressure control, anesthetic monitoring and general anesthesia were performed. A 12-14 cm was made on the skin in the presternal region followed by a median sternotomy. Left internal thoracic artery was dissected and skeletonized, taking care to avoid the opening of the pleura, and used for revascularization of anterior interventricular artery. The other vascular graft used was the great saphenous vein directed to the other coronary beds, dissected through incisions in the medial side of the thigh. All patients underwent dialysis on the day prior to the surgery.

*Technique with ECC*: Heparin administration at 4mg/kg was performed before aortic and atrial cannulation (double-staged cannula). The ECC was established after an activated clotting time (ACT) greater than 480 seconds was confirmed. During cardiac arrest induced by aortic clamping, myocardial protection with intermittent antegrade cold blood cardioplegia was performed every 15 minutes.

*Technique without ECC*: heparin and ACT control were administered at 2 mg/kg 10 minutes before coronary occlusion. Distal anastomoses were performed using *Octopus*® (*Medtronic*, Inc.) vacuum stabilizers and with proximal occlusion of the arteries. The anastomoses were carried out by priority of arteries with total occlusion.

Statistical analysis
--------------------

Quantitative variables were expressed as means and categorical variables as percentage. The Mann-Whitney test was used for comparison of quantitative variables and the Fisher\'s exact test for comparison of categorical variables. The level of significance was set at 5%. The statistical tests were performed using the BioEstat 5.0 software.

Results
=======

A total of 102 patients were included in the study, 63 underwent myocardial revascularization surgery with ECC and 39 without ECC. Demographical and laboratory data are described in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}, respectively. A high prevalence of cardiovascular risk factors was observed, with no statistically significant difference though. Three patients were under immunosuppressive and dialytic therapy due to kidney transplant rejection. Intraoperative data showed that patients operated with ECC had more revascularization of coronary arteries, required inotropic support and transfusion of blood derivatives more often, and used intra-aortic balloon pump in two occasions ([Table 3](#t3){ref-type="table"}).

###### 

Demographic characteristics

  Characteristics                              With ECC n = 63   Without ECC n = 39   p
  -------------------------------------------- ----------------- -------------------- --------
  Age (years)                                  56.7              56.0                 0.9316
  Female sex (%)                               22.2              30.7                 0.3581
  Time of dialysis (years)                     2.9               4.4                  0.8966
  Hypertension (%)                             100               100                  1.0000
  Diabetes (%)                                 80.9              66.6                 0.1544
  Dyslipidemia (%)                             36.5              33.3                 0.8325
  Obesity (%)                                  12.6              15.3                 0.5250
  Smoking (%)                                  9.5               5.1                  0.4837
  Chronic obstructive pulmonary disease (%)    0                 0                    1.0000
  Previous stroke (%)                          14.2              12.8                 1.0000
  Previous angioplasty (%)                     22.2              23.0                 1.0000
  Heart failure (%)                            19.0              10.2                 0.2757
  Previous acute myocardial infarction (%)     15.8              20.5                 0.5988
  Peripheral arterial disease (%)              14.2              15.3                 1.0000
  Stable angina (%)                            14.2              23.0                 0.2923
  Unstable angina (%)                          11.1              12.8                 0.9999
  Left coronary trunk lesion (%)               9.5               15.3                 0.5284
  Preserved ventricular function (LVEF\>50%)   85.7              71.7                 0.1228
  EuroSCORE II (%)                             2.93              2.77                 0.9784

ECC: extracorporeal circulation; LVEF: left ventricular ejection fraction.

###### 

Dados laboratoriais pré-operatórios

  Laboratory variable (mean)   With ECC n = 63   Without ECC n = 39   p
  ---------------------------- ----------------- -------------------- --------
  Creatinine (mg/dL)           7.8               8.2                  0.5261
  Urea (mg/dL)                 110.9             120.3                0.1348
  Hemoglobin (g/dL)            11.2              12.1                 0.3350
  Sodium (mEq/L)               135.8             135.4                0.6935
  Potassium (mEq/L)            4.8               5.1                  0.3578

ECC: extracorporeal circulation.

###### 

Intraoperative data

  Variable                   With ECC n = 63   Without ECC n = 39   p
  -------------------------- ----------------- -------------------- ----------
  Number of anastomoses      2.4               1.7                  \<0.0001
  Inotropic support (%)      82.5              35.8                 \<0.0001
  Transfusion (%)            77.7              25.6                 \<0.0001
  Intra-aortic balloon (%)   3.1               0                    0.5230
  Intraoperative death (%)   0                 0                    1.0000

ECC: extracorporeal circulation.

Data of postoperative course are found in [Table 4](#t4){ref-type="table"}. The most frequent complications were atrial fibrillation, infection and prolonged mechanical ventilation. Patients with ECC surgery had lower infection rate, required less vasoactive drugs and shorter time of mechanical ventilation and ICU stay, as well as greater success in weaning from mechanical ventilation in the operative room.

###### 

Postoperative data

  Complication                                 With ECC n = 63   Without ECC n = 39   p
  -------------------------------------------- ----------------- -------------------- --------
  Surgical reexploration (%)                   3.1               2.5                  1.0000
  Postoperative infarction (%)                 3.1               5.1                  0.6356
  Atrial fibrillation (%)                      25.3              17.9                 0.4686
  Use of vasoactive drug (%)                   82.5              61.5                 0.0340
  Time of use of vasoactive drug (days)        3.5               2.9                  0.1915
  Extubation in the operative room (%)         23.8              58.9                 0.0006
  Ventilation for more than 24 hours (%)       15.8              10.2                 0.5583
  Duration of mechanical ventilation (hours)   36.3              13.0                 0.0217
  Stroke (%)                                   1.5               5.1                  0.5564
  Infection (%)                                28.5              7.6                  0.0120
  Rehospitalization within 30 days (%)         1.5               0                    1.0000
  Incision complications (%)                   3.1               2.5                  1.0000
  Vasoplegia (%)                               11.1              2.5                  0.1498
  In-hospital mortality (%)                    12.6              5.1                  0.3103
  Time ICU stay (days)                         8.1               5.2                  0.0054
  Time of hospital stay (days)                 13.0              10.8                 0.5921

ECC: extracorporeal circulation; ICU: intensive care unit.

Discussion
==========

Chronic renal failure is an independent factor for coronary heart diseases and culminates in higher risk of perioperative morbidity and mortality. The study group showed high prevalence of cardiovascular risk factors, such as hypertension, diabetes, dyslipidemia, and history of cardiovascular diseases, similar to those reported in the CHOICE study.^[@r3]^ With respect to these aspects, no statistically significant differences were detected between the groups, indicating that they were comparable in terms of demographic variables. However, the greater number of revascularizations performed in the group operated with ECC (p\<0.0001) suggests higher severity of coronary disease (the SYNTAX Score could not be obtained from the available data), and hence a possible selection bias. This was predictable and understandable, since the technique without ECC hinders the revascularization of coronaries in the posterior territory, which explains the greater number of patients with three-vessel disease in the group with ECC surgery. Despite the greater number of diseased arteries in the ECC group, no difference between the groups in mortality risk was detected by the EUROScore II.

Patients operated without ECC required less inotropic support and blood transfusion during surgery (p\<0.0001), similar to that reported by other authors \[20\]. In the postoperative course, patients without ECC surgery were extubated earlier, required less vasoactive drugs (82.5% vs. 61.5% p = 0.0340) and had lower infection rate (28.5% vs. 7.6% p = 0.0120) as compared with patients with ECC surgery. These data reflect the intense inflammatory response triggered by the passage of blood through non-endothelial surfaces of ECC, leading to vasoplegia, increased need for vasopressors and higher morbidity and mortality. In contrast to previously reported by other authors and by us, there was no statistically significant difference in in-hospital mortality between the groups, with a tendency of higher mortality in the group of patients that underwent surgery with ECC (12.6% vs. 5.1% p = 0.3103).^[@r14]-[@r16],[@r21]^

The low mortality in the group without ECC is comparable to studies by Milani et al. and Fukushima et al., in which revascularization without ECC had low morbidity, without occurrence of death during hospital stay.^[@r22],[@r23]^

Conclusion
==========

Myocardial revascularization surgery is feasible in patients on dialysis, despite higher morbidity and mortality rates as compared with the general population. As compared with the surgery without ECC, the use of ECC resulted in longer duration of mechanical ventilation and longer ICU stay, increased need for blood derivatives, and inotropic and vasoactive drugs, higher incidence of infection and lower extubation rate in the operating room. However, no statistically significant difference in mortality was detected between the groups. These results suggest that myocardial revascularization surgery without ECC in dialytic patients promotes lower mortality during hospitalization, without affecting short-term mortality.
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